FILL/FINISH OUTSOURCED PHARMA CAPACITY UPDATE VIDEOS

18:43 Simtra-Biopharma-Solutions-Capabilities-Update-October-2026-Fill-Finish
Simtra Biopharma Solutions Capabilities Update October 2026: Fill Finish

Explore new sterile manufacturing capacity for pre-filled syringes, lyophilized vials, and potent therapies, supporting flexibility, scale, and supply resilience.

19:26 PCI-Pharma-Services-Capabilities-Update-October-2026-Fill-FInish
PCI Pharma Services Capabilities Update October 2026: Fill FInish

PCI integrates scalable manufacturing, packaging, device assembly, and global regulatory expertise to streamline tech transfer and strengthen supply chain resilience.

15:28 Alcami-Capabilities-Update-October-2026-Fill-Finish
Alcami Capabilities Update October 2026: Fill Finish

Discover critical considerations for sterile fill-finish, including manufacturability, scale-up, contamination control, and the path from clinical to commercial supply.

19:00 lonza biologics drug product fill finish opcu 2026
Lonza Capabilities Update October 2026: Fill/Finish

Bastian Klöfer, Director of Commercial Development, Drug Product Services, explores Lonza's end-to-end biologics network, spanning drug substance, drug product development, manufacturing, analytics and regulatory support.

22:31 thermo fill finish october opcu 2026
Thermo Fisher Scientific Capabilities Update October 2026: Fill/Finish

Learn how to balance technical, regulatory, and supply chain considerations while avoiding costly late-stage changes and preparing for successful technology transfer, scale-up, and commercialization.

19:08 FUJIFILM-Biotechnologies-Capabilities
Reducing Risk Across The Global Fill-Finish Supply Chain

Discover end-to-end drug product filling and packaging across FUJIFILM Biotechnologies' global network, designed to protect products and support seamless delivery to patients.

18:07 Kindeva Capabilities Update
Advancing Sterile Fill-Finish For Injectable Therapies

The session will highlight the site’s advanced aseptic manufacturing infrastructure, automated filling technologies and scalable capacity designed to support clinical and commercial injectable products.

14:36 Resilience-LLC-July-OPCU
Resilience Capabilities Update July 2026: Fill/Finish

Learn how expanding capacity, automation, and flexible manufacturing technologies are helping biologics manufacturers meet evolving market and quality demands.

19:30 thermo steriles biologics opcu
Thermo Fisher Scientific Capabilities Update July 2026: Fill/Finish

When working with high-value biologics, ADCs, and personalized medicines, material utilization decisions made before GMP manufacturing can make or break your program yield. Learn how early choices matter.

17:13 Pace Life Sciences Capabilities Update July 2026: Fill/ Finish
Pace Life Sciences Capabilities Update July 2026: Fill/ Finish

Flexible CDMO networks separate early formulation from clinical fill-and-finish, using manual and automated isolators to protect delicate modalities while accelerating trial timelines.

22:11 Ardena Capabilities Update July 2026: Fill/Finish
Ardena Capabilities Update July 2026: Fill/Finish

Grade A isolators and sterilization protect delicate biologics. Precision container closures maintain integrity down to -80°C, ensuring full compliance across clinical fill-and-finish workflows.

17:53 Simtra Capabilities Update April 2026: Fill/Finish
Simtra Capabilities Update April 2026: Fill/Finish

A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.

20:40 Upperton OPCU
Upperton Capabilities Update April 2026: Fill/Finish

An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.

15:48 Kindeva Capabilities Update April 2026: Fill/ Finish
Kindeva Capabilities Update April 2026: Fill/ Finish

An overview of sterile fill‑finish capabilities showcasing automated aseptic technologies, scalable capacity, and collaborative approaches for efficient, reliable injectable supply.

18:19 Grand River Aseptic Manufacturing Capabilities Update April 2026: Fill/Finish
Grand River Aseptic Manufacturing Capabilities Update April 2026: Fill/Finish

A sterile injectable CDMO providing fill‑and‑finish services across vials, syringes, and cartridges, supported by isolator-based filling lines and biologics-ready scale.

16:59 August BioServices Capabilities Update April 2026: Fill/Finish
Advancing Sterile Injectable Manufacturing

A U.S.-based sterile injectable CDMO delivering scalable small and large molecule manufacturing, supported by advanced aseptic technologies, integrated quality systems, and commercial-ready capabilities.

16:37 rois-capabilities-update-march-2026-rois-cdmo
ROIS Capabilities Update March 2026: Fill/Finish

End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.

13:24 Novartis Capabilities Update March 2026 FillFinish
Novartis Capabilities Update March 2026: Fill/Finish

Integrated fill‑finish capabilities across multiple sterile formats improve workflow efficiency, enhance product consistency, and support effective planning for scaling and long‑term commercialization.

17:38 medac-cdmo-capabilities-update-march-2026-medac-cdmo-fill-finish-capacity-update
medac CDMO Capabilities Update March 2026: Fill/Finish

A purpose‑built sterile manufacturing model enables reliable scale‑up, operational agility, and resilient global supply for complex injectables, supported by strong infrastructure and process design.

15:15 Jubilant HollisterStier Capabilities Update March 2026: Fill/Finish
Jubilant HollisterStier Capabilities Update March 2026: Fill/Finish

Reliable sterile manufacturing requires tailored support and consistent execution. Collaboration and strong quality systems help teams advance complex injectable products with confidence.

19:38 Argonaut Capabilities Update March 2026 FillFinish
Argonaut Capabilities Update March 2026: Fill/Finish

Aseptic, isolator‑based fill‑finish spans multiple formats and batch sizes, supported by onsite analytics that cut hand‑offs and streamline testing. Learn how this setup boosts efficiency.

19:45 Bora Pharmaceuticals
Commercially Proven Sterile Fill/Finish With Capacity And Global Backing

Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

12:39 pci jan 26 opcu ff
PCI Pharma Services Capabilities Update January 2026: Fill/Finish

Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.

7:00 afton jan 26 ff
Afton Scientific Capabilities Update January 2026: Fill/Finish

Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

Agenda & Presenter Details

Visit our registration pages to see the current agenda and our list of presenting sponsors.

How can we help?

Are you a supplier looking to present at our next event?

Become A Presenter